LiveMetric
Wearable Blood Pressure Monitoring Device
Company Overview
Snapshot
Founded in December 2015 by Tomer Bentzion, LiveMetric operates with 11–50 employees. The company has raised $24.02 million across two funding rounds from one investor. In July 2022, LiveMetric received FDA 510(k) clearance for its watch-like blood pressure monitor.
Business overview
LiveMetric develops continuous, wearable blood pressure monitoring solutions for hypertension and cardiovascular disease. The company's core technology incorporates proprietary sensor technologies coupled with AI insights to provide a cuffless, wearable, continuous blood pressure monitor that does not require calibration. The LiveMetric platform delivers hundreds of accurate blood pressure measurements, heart rate, heart rate variability, and steps taken, enabling real-time, personalized care. The platform, which has received FDA clearance and is clinically validated, serves both B2C and B2B markets, allowing providers to integrate data into medical record systems.
Strategic signal
In January 2023, LiveMetric partnered with Solve.Care to enhance the data security of its continuous blood pressure monitoring using blockchain technology. This collaboration signals LiveMetric's commitment to leveraging advanced technologies to secure sensitive patient data, which is crucial for increasing trust and adoption in digital health solutions and could provide a competitive advantage in the remote patient monitoring market.
Company Intelligence Q&A
- What is LiveMetric's primary product?
- LiveMetric's primary product is LiveOne, a continuous, wearable blood pressure monitoring device designed for hypertension and cardiovascular disease management.
- When was LiveMetric founded?
- LiveMetric was founded in December 2015.
- Has LiveMetric received any regulatory clearances?
- Yes, in July 2022, LiveMetric received FDA 510(k) clearance for its watch-like blood pressure monitor.
- What was a significant partnership for LiveMetric in 2023?
- In January 2023, LiveMetric announced a partnership with Solve.Care to enhance the data security of continuous blood pressure monitoring using blockchain technology.
- Who is a lead investor in LiveMetric?
- Upheaval Investments led a funding round for LiveMetric in May 2019.